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Abstract 
Plasmodium parasites are transmitted by Anopheles mosquitoes to the 
mammalian host and actively infect hepatocytes after passive transport in the 
bloodstream to the liver. In their target host hepatocyte, parasites reside within 
a parasitophorous vacuole (PV). In the present study it was shown that the 
parasitophorous vacuole membrane (PVM) can be targeted by autophagy 
marker proteins LC3, ubiquitin, and SQSTM1/p62 as well as by lysosomes in a 
process resembling selective autophagy. The dynamics of autophagy marker 
proteins in individual Plasmodium berghei-infected hepatocytes were followed 
by live imaging throughout the entire development of the parasite in the liver. 
Although the host cell very efficiently recognized the invading parasite in its 
vacuole, the majority of parasites survived this initial attack. Successful 
parasite development correlated with the gradual loss of all analyzed 
autophagy marker proteins and associated lysosomes from the PVM.  
However, other autophagic events like non-selective canonical autophagy in 
the host cell continued. This was indicated as LC3, although not labeling the 
PVM anymore, still localized to autophagosomes in the infected host cell. It 
appears that growing parasites even benefit from this form of non-selective 
host cell autophagy as an additional source of nutrients, as in host cells 
deficient for autophagy, parasite growth was retarded and could partly be 
rescued by the supply of additional amino acid in the medium. Importantly, 
mouse infections with P. berghei sporozoites confirmed LC3 dynamics, the 
positive effect of autophagy activation on parasite growth, and negative effects 
upon autophagy inhibition. 
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Introduction 
Plasmodium parasites are the causative agents of malaria, a disease that still affects 
more than 300-500 million people and kills several hundred thousands yearly. 
Plasmodium parasites are transmitted by Anopheles mosquitoes and injected into the 
skin of the vertebrate host as motile sporozoites. For further development, these 
sporozoites have to first find their way to a blood vessel1 before being transported 
passively by the blood stream to the liver. Within the liver, motile sporozoites migrate 
along the endothelia and pass through Kupffer cells or endothelial cells to reach their 
target hepatocyte.1 Sporozoites transmigrate through a number of hepatocytes, until 
finally settling in one where they undergo growth and asexual replication. Sporozoites 
invade their host cell by invagination of the host cell plasma membrane and the 
formation of a parasitophorous vacuole membrane (PVM). Upon invasion, the 
parasite massively modulates the PVM by export of numerous proteins. Although it 
has been speculated that proteins are also secreted into the host cell, and that they 
can manipulate host cell signaling, so far this observation has been confirmed only 
for very few proteins.2 Inside the parasitophorous vacuole (PV), rodent Plasmodium 
species transform within the first 16 hours to a trophozoite, and later, a schizont 
stage. The liver schizont stage is characterized by an extraordinary growth and 
nuclear replication that lasts approximately 30 hours. In the last few hours of liver 
stage development, the parasite plasma membrane starts to invaginate, forming 
thousands of merozoites that are released into the host cell cytoplasm upon PVM 
rupture. PVM rupture induces an ordered form of host cell death that is characterized 
by host nucleus condensation but not by fragmentation of the DNA.3 Importantly, 
merozoites accumulate Ca2+ released from host cell stores during cell death and 
thus block exposure of phosphatidylserine residues to the outer leaflet of the 
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membrane of the infected cell. Host cell death also allows the formation of 
merosomes, vesicles that bud from the host cell membrane and are filled with 
merozoites. By a so far unknown mechanism, merosomes are pushed into the blood 
vessel while merozoites continue to be transported in the budding vesicle. 
Merosomes are liberated and transported into the lung capillaries where they release 
merozoites to initiate infection of red blood cells, marking the beginning of the 
pathogenic phase of the infection.4 
In our present work, we studied two main types of autophagy that influence 
parasite establishment, growth and development: on one hand, the host cell 
response selectively targeting Plasmodium parasites (selective autophagy), and on 
the other hand non-selective canonical autophagy potentially supporting parasite 
nourishment. Recently it has been shown that the autophagy marker protein LC3 is 
recruited to the PVM and to tubules budding from the PVM5 but nothing is known 
about canonical host cell autophagy and its effect on parasite development. 
Although intracellular pathogens like Plasmodium avoid direct contact with the 
host adaptive or innate immune responses, the invaded host cell is also equipped 
with a plethora of mechanisms to eliminate the invader.6,7 These mechanisms can be 
considered to be cytosolic immune responses. One prominent cytosolic immune 
mechanism is selective autophagy, which also serves as a catabolic process to 
recycle damaged organelles or large protein complexes.8 Selective autophagy differs 
from canonical autophagy in that it specifically targets intracellular pathogens or 
intracellular components by ubiquitination, and does not induce the general 
autophagy response of the cell that is elicited upon starvation. Similar to canonical 
autophagy, upon selective autophagy, double-membrane structures called 
phagophores form around invaded pathogens or damaged organelles. 
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Another autophagy-related response of host cells to pathogens residing in a 
vacuole is to directly target the vacuolar membrane and label it for fusion with 
lysosomes in a process called LC3-associated phagocytosis (LAP).9 LC3 targeting of 
membranes is a common feature of most autophagy-related processes.10,11 LC3 is a 
ubiquitous cytosolic protein and, like other proteins of the autophagy machinery, it is 
constitutively expressed8 and can be immediately recruited when autophagy is 
induced. LC3 is synthesized as a precursor and the C-terminus is processed by the 
cysteine protease ATG4. This generates LC3-I, in which a C-terminal glycine 
becomes exposed, thus becoming available for the subsequent conjugation 
reactions. LC3-I is activated by ATG7, transferred to the E2-like enzyme ATG3, and 
finally, with the help of the ATG12-ATG5-ATG16 complex (which acts as an E3-like 
enzyme), conjugated with phosphatidylethanolamine (PE) to form LC3-II. In canonical 
autophagy, LC3-II localizes to target membranes such as autophagosomal 
membranes. In non-canonical autophagy processes such as LAP, LC3-II localizes to 
membranes of pathogen-containing compartments. Due to the different localization 
patterns of LC3-I and LC3-II, LC3-II is considered to be a key marker protein for all 
different forms of autophagy.9-11  
Several pathogens have developed strategies to circumvent autolysosomal 
degradation.12-14 It has been shown that Toxoplasma gondii interferes with Akt 
signaling to block autophagy but it has also been suggested for the same parasite 
that it even can exploit autophagy as an additional source of nutrients.13 An 
explanation for these results, which at first glance may seem contradictory, might be 
the difference of selective autophagy that needs to be controlled by the parasite to 
avoid elimination, and canonical autophagy that might be exploited by the pathogen.  
In the present study, the autophagic response of hepatocytes to the invasion 
of Plasmodium sporozoites was examined. Since biochemical analysis of 
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Plasmodium-infected hepatocytes is limited by the low infection rate, we developed 
long-term live imaging to follow individual infected cells. This approach allowed us to 
record for the first time the entire 64-hour development period of individual parasites 
that successfully invaded a hepatocyte, developed into merozoites, and were 
released into the host cell cytoplasm, thereby inducing cell detachment in vitro. We 
found that the invaded Plasmodium sporozoites failed to control the initial LC3 
labeling of the PVM and some were even eliminated by autophagy. However, the 
surviving parasite majority appeared to be able to control the progression of the 
autophagic process by an as-yet unknown mechanism. Indeed, these surviving 
parasites appeared to benefit from non-selective canonical autophagy as an 
additional source of nutrients.  
 
Results  
The host cell recognizes and labels invading sporozoites  
To analyze the selective autophagy-related mechanisms that arise while Plasmodium 
is infecting hepatocytes, we used the murine malaria model Plasmodium berghei. We 
first examined whether sporozoite infection of hepatocytes causes the cytosolic LC3 
protein to localize to autophagosomes. Immunofluorescence analysis (IFA) of P. 
berghei-infected primary hepatocytes stained with an anti-LC3 antibody revealed that 
the localization of endogenous LC3 differed depending on the stage of parasite 
development (Fig. 1A). During sporozoite invasion, LC3 accumulated in 
membranous structures around the parasite, whereas in late schizogony LC3-positive 
vesicles were more randomly distributed throughout the cytoplasm of the host cell.  
Although the original observation of LC3 accumulation around early parasite stages 
was made in primary mouse hepatocytes, it was essential to validate this observation 
in vivo. To follow the dynamic events of LC3 recruitment after sporozoite invasion, we 
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used mCherry-expressing parasites to infect transgenic mice that express in all 
nucleated cells LC3 N-terminally tagged with green fluorescent protein (GFP). 
Intravital imaging of the liver of an infected mouse revealed a pattern of LC3 
distribution around the parasite in the early developmental stages, which was not 
seen in the later stages (Fig. 1B) that resembled the pattern we also observed in 
vitro (Fig. 1A). Importantly, intravital imaging indicated that even late-stage parasites 
are occasionally eliminated in an autophagy-typical manner (Fig. 1C; Vid. S1). This 
phenomenon was also observed in vitro (Vid. S2). Since the same effect was 
observed in vitro and in vivo it could be concluded that LC3 accumulation around the 
parasite is indeed a physiological event and not restricted to in vitro cultivated cells. It 
further proves that both, the in vitro analysis and the GFP-LC3 mouse are suitable 
and complementary models for studying autophagy in Plasmodium-infected 
hepatocytes. 
To study the dynamics of LC3 localization, we transfected the hepatoma cell 
line HepG2 with a plasmid encoding GFP-LC3 and infected these cells with P. 
berghei sporozoites expressing the red-fluorescent protein mCherry. Live imaging 
approaches revealed that in the vast majority of infected cells, GFP-LC3 was 
immediately and dramatically recruited into a membrane around the parasite after 
invasion (Fig. 2A; Vid. S3). This confirms the IFA data (Fig. 1A) and suggests that 
the host cells recognize the invader and mount a strong cytosolic immune response 
against it. Thereafter, however, although a considerable number of parasites were 
indeed eliminated between 9 and 24 hours post-infection (Fig. 2B), the LC3 
accumulation around the majority of parasites was progressively lost suggesting that 
the parasites escaped this host cell response (Fig. 2A; Vid. S4, S5 and S6).  
Before wild-type (WT) LC3 can accumulate around the invaded sporozoite, it 
must be correctly processed, lipidated, and incorporated into a membrane. When 
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HepG2 cells were transfected instead with a plasmid encoding the GFP-LC3G120A 
mutant, which cannot be processed and lipidated10, mutant LC3G120A was not 
mobilized around the invaded parasite (Fig. S1) suggesting that processing and 
lipidation are prerequisites for the observed LC3 accumulation around the parasite. It 
is important to note that the cells transfected with the GFP-LC3G120A mutant construct 
still express the endogenous and thus functional LC3. Therefore, it is unlikely that 
expression of the GFP-LC3G120A mutant would affect parasite development.  
Next, we wanted to know whether the host cell isolates the parasite in an 
autophagosome. Electron microscopic (EM) analysis of P. berghei–infected HepG2 
cells did not reveal the formation of a typical autophagosomal membrane around the 
invading parasite (Fig. 2C) confirming previous EM studies examining in great detail 
P. berghei development in vitro and in vivo.15-17 This hinted that upon sporozoite 
invasion, LC3 must be incorporated into another membrane.  
One such membrane may be the PVM, which is a membrane that surrounds 
parasites. Indeed, when P. berghei-infected HepG2 cells were stained with an 
antiserum against the PVM marker protein UIS4 and an anti-LC3 antibody, super 
resolution STED microscopy revealed a clear co-localization of both markers (Fig. 
3A).  
LC3 labeling of the PVM during early parasite development was further 
confirmed by confocal microscopy of GFP-LC3-expressing HepG2 cells additionally 
stained with an anti UIS4 antiserum (Fig. 3B, upper two panels). However, in the 
later stages, LC3 accumulation around the PVM diminished; instead, the protein 
formed LC3-positive aggregates around the PVM and throughout the cytoplasm (Fig. 
3B, lower panel). It is possible that the parasites actively clear the PVM of this 
autophagy marker protein, most likely to prevent progression of the destructive 
events in the PV that could result in parasite elimination. Supporting this view is the 
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fact is that the parasites whose PVMs continued to bear ample amounts of LC3 in the 
later stages did not complete liver stage development (Fig. 3C and D; Vid. S7). 
Instead, they often underwent a kind of cell death that has been previously 
reported.18 Indeed, the late liver-stage schizonts that continued to have an LC3-
positive PVM were significantly smaller than the parasites whose PVM lost LC3 (Fig. 
3D). Thus, LC3 persistence in the PVM is associated with parasite growth arrest and 
elimination.  
 
Lysosomes are attracted by early-stage and arrested parasites  
Having confirmed that LC3 labeling of the PVM and subsequent autophagy-related 
events can limit parasite infection to a certain extent, we next investigated the events 
that occur up- and downstream of the labeling of the PVM in infected cells with LC3. 
A hallmark of autophagy is the fusion of LC3-positive autophagosomes with 
lysosomes, which generates lysogenic autolysosomes.19 One study suggested that 
lysosomes fuse with the PVM in P. berghei-infected hepatocytes.20 We therefore 
sought to determine i) the dynamics of lysosome fusion in relation to LC3 recruitment 
to the PVM in infected cells, ii) whether the pH drops in the PV, and iii) whether the 
lysosomal protease cathepsin D is recruited to the PV.  
 To follow the dynamics of lysosomes in infected cells and to quantify the 
corresponding observations, we used several live and indirect staining methods. 
LAMP1 is a protein of the lysosomal membrane21 and can either be tagged by GFP 
or detected by IFA using antibodies. Other methods that we used for live imaging 
were to employ a RFP-tagged version of cathepsin D,22 which is the main lysosomal 
protease and to stain cells with LysoTracker, which detects lysosomes because of the 
low pH in these compartments. Finally, to visualize protein degradation in lysosomes, 
DQ-BSA was used. Unprocessed DQ-BSA is colorless because its fluorogenic group 
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is quenched. On processing, DQ-BSA emits red fluorescence and thus labels 
degradation vesicles like lysosomes and autolysosomes.  
The main observation from the experiments using these different staining 
approaches was that while lysosomes accumulated around the early-stage parasites, 
this association was progressively lost during parasite development (Fig. 4 Fig. S2-
S5). All lysosome markers, namely, LysoTracker, DQ-BSA, cathepsin D, and LAMP1, 
appeared to be closely associated with the PVM and LC3 (Fig. S3-S5) at early 
parasite stages and show a more random distribution in the host cell at later 
developmental stages. Furthermore, in the early parasite stages LAMP1 was found to 
partially co-localize with UIS4 and thus the PVM (Fig. S3 Vid. S8), which strongly 
suggests that the lysosomes fused with the PVM. However, this LAMP1 incorporation 
into the PVM was eventually lost, similar to what was observed for LC3.  
Another important observation of these staining experiments was that the PV 
did not become positive for LysoTracker, cathepsin D-RFP, or DQ-BSA (Fig. 4A, S2 
and S4). This suggests that even though the PV fused with lysosomes, this event did 
not enhance the degradation properties of the vacuole.  
Finally, we investigated the fate of the arrested parasites and compared them 
to normally developing parasites. At later stages, the arrested parasites remained 
LAMP1-, LysoTracker-, and LC3-positive, which indicated that these parasites were 
in the process of being eliminated (Fig. 5 and 3C). Elimination of an arrested LC3-
positive parasite can be observed in Video S5.  
These observations together suggest that while the host cells try to isolate 
the invading parasites in LC3-positive compartments, they are not able to eliminate 
the majority of these parasites within these vacuoles by acidification through fusion 
with lysosomes. Thus, even though lysosomes associate with the PVM at an early 
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stage, the majority of parasites avoid acidification, protease activation and 
degradation.  
 
LC3 recruitment to the PVM is the result of a novel form of autophagy 
There are several pathways that could potentially trigger the observed LC3 labeling 
of the PVM in P. berghei-infected hepatocytes. One is LAP, which is characterized by 
a series of clearly defined molecular events.9,23 A hallmark of LAP is the initial 
labeling of the target membrane by phosphatidylinositol 3-phosphate (PI(3)P) and a 
transient labeling by Beclin-1. Since we did not find (PI(3)P) and Beclin-1 in the PVM 
(data not shown) and because we have identified ubiquitin and SQSTM1 localization 
to the PVM (see below), we excluded LAP as a possible mechanism. 
Another process that targets LC3 to a membrane is selective autophagy, in 
which target membranes are labeled with ubiquitin and the adaptor protein SQSTM1 
that then recruits LC3.24-27 However, in selective autophagy, a newly formed 
phagophore is generated to isolate the target compartment.8 Since the presence of 
this additional membrane was excluded by EM analysis (Fig. 2), selective autophagy 
as it has been characterized so far was also excluded as a possible autophagic 
mechanism as well.  
To our surprise, we then found that the PVM became positive for ubiquitin, 
SQSTM1, and LC3, all with very similar kinetics (Fig. 6A and B, Fig. 7A and B; Vid. 
S9). Still, so far it is not clear whether ubiquitination is connected with labeling of the 
PVM with LC3 and lysosomes. To exclude the possibility that ubiquitination of the 
PVM depends on LC3, we infected GFP-ubiquitin-expressing Atg5-/- and control 
MEFs with P. berghei sporozoites. Although the Atg5-/- MEFs are deficient in LC3 
processing and lipidation,28 both cell lines showed early ubiquitination of the PVM 
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(Fig. 6C). This further supports the hypothesis that a mechanism related to selective 
autophagy is activated on P. berghei invasion.  
Importantly, in infected HepG2 cells the PVM of arrested parasites stayed 
positive for all markers, namely, ubiquitin, SQSTM1 (Fig. 8A and B), and LC3 (Fig. 
3C). This suggests that this PVM labeling pattern associates with parasite 
elimination. However, the majority of parasites escaped this advanced stage of 
autophagy. The molecular basis of this escape mechanism is currently unknown. 
 
Galectins do not mediate labeling of the PVM  
Galectins have been shown to target damaged bacteria-containing vacuoles for 
autophagy, in order to defend cells against bacterial invasion.29 To investigate 
whether galectins are also recruited to the PVM in P. berghei-infected cells, we 
transfected HepG2 cells with constructs that allow expression of fluorescently tagged 
galectin 1, 3, 8 and 9. When we infected these transfected cells with P. berghei 
sporozoites we did not observe a marked labeling of the PVM, suggesting that none 
of the galectins investigated play an important role the recruitment of LC3 to the PVM 
(Fig. S6A-C). 
 
Starvation-induced autophagy promotes parasite growth and survival 
To test whether enhanced autophagy has an effect on parasite development we 
wanted to analyze parasite development in vivo under starvation conditions. For that 
we generated a P. berghei ANKA reporter line (PbmCherryhsp70+Luceef1α),  which 
expresses luciferase under the control of the eef1α (PBANKA_113330) promoter and, 
in addition, mCherry under the control of hsp70 (PBANKA_071190) promoter (Fig. 
S7A-D). Parasites of this line express luciferase and mCherry throughout the life 
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cycle. The life cycle progression of this line in the blood, mosquito and liver stage 
development is comparable to that of wild type P. berghei ANKA parasites (Fig. S7E).  
Balb/c mice were starved and infected with the luciferase-expressing P. berghei line 
PbmCherryhsp70+Luceef1α, and parasite growth in the liver was monitored until 
transition to the blood stage (Fig. 9A). We followed two different regimens: mice were 
either pre-starved 12 hours before infection or they were starved upon infection. 
Surprisingly, both starvation regimens resulted in an increased parasite load in the 
liver with a peak at 48 hpi (Fig. 9B). To analyze whether starvation induces canonical 
autophagy, GFP-LC3 mice were starved and monitored by intravital imaging 30 hours 
later (Fig. S8). Significantly higher numbers of GFP-LC3 positive autophagosomes 
upon starvation indeed confirmed increased autophagy levels. Together, canonical 
non-selective autophagy appears to even support parasite development in 
hepatocytes.  
To examine whether the increased parasite load is due to more surviving parasites or 
increased parasite growth, Balb/c and C57B/6 mice were infected with P. berghei and 
the size and the numbers of intracellular parasites were analyzed on histological 
sections (Fig. 9C and D). Liver sections of non-starved mice served as control. At 24 
hpi the number of parasites was significantly increased in the starved animals; this 
was even more pronounced at 36 and 44 hpi. The fact that in starved animals the 
relative number of parasites was higher at later stages indicates that the number of 
control parasites must have decreased over time. This confirms our original in vitro 
observations that a considerable number of parasites are eliminated during their 
development from sporozoite to liver schizont. Importantly, although the absolute 
number of infected hepatocytes differed substantially among Balb/c and C57B/6 
mice, there was no significant difference in the relative number in both mouse strains 
when comparing starved and control mice. In conclusion starvation-induced 
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autophagy had similar effects on parasite development independent of the mouse 
strain used suggesting very general autophagy mechanisms in different mouse 
stains. This confirms that both animal models are suited to study autophagy-related 
events upon Plasmodium infection. 
 
Drug-mediated manipulation of autophagy has a profound effect on parasite 
growth and survival 
To confirm that inducing canonical autophagy has a positive effect on parasite 
development, an in vivo drug-based approach was employed. Rapamycin is a well-
known inhibitor of the gatekeeper of autophagy, mTOR and thus a strong inducer of 
autophagy. Chloroquine blocks autophagy by preventing the fusion of lysosomes with 
autophagosomes. Mice were treated with the either of the two drugs, before or after 
infection with luciferase-expressing P. berghei PbmCherryhsp70+Luceef1α sporozoites. 
As observed in the starvation experiment, the autophagy-inducing drug rapamycin 
had a strong positive effect on parasite liver load whereas the autophagy inhibitor 
chloroquine had the opposite effect (Fig. 10A and B, Fig. S9). The strongest effects 
were observed in mice pre-treated with the drugs. In contrast to starvation-induced 
autophagy, increased parasite load at 40 hpi in rapamycin-treated mice were solely 
due to increased parasite numbers not to enhanced growth of the parasite in the liver 
(Fig. 10C and D). Interestingly, also chloroquine treatment did not significantly affect 
parasite size at this time. Lower parasite load in the liver was due to less infected 
cells at the end of liver stage development. Intravital imaging of GFP-LC3 mice was 
again employed to confirm that rapamycin induces autophagy (Fig. S8). Actually, in 
comparison to starvation, rapamycin treatment resulted in a dramatically higher 
number of GFP-LC3 positive autophagosomes. 
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Together, the in vivo experiments strongly suggest that manipulation of autophagy 
has profound effects on parasite development and growth. 
 
Inhibition of LC3 recruitment to the PVM promotes parasite establishment in 
host cells 
Since starvation and drug treatment can have many off-target effects in mice, we next 
aimed for a more specific in vitro approach to test whether blocking the autophagy 
machinery affects parasite growth and development. We took advantage of the fact 
that P. berghei sporozoites infect a wide variety of cells, including murine embryonic 
fibroblasts (MEFs). We used an Atg5-/- MEF cell line in which the pathway that leads 
to LC3 lipidation is blocked.28 Thus, in Atg5-deficient cells, all events that depend on 
correct LC3 lipidation and membrane association, including autophagy, are 
interrupted. First, we confirmed that Atg5-/- MEFs are deficient in LC3 lipidation upon 
starvation of the cells by IFA with anti-LC3 antibodies. The knockout and WT MEFs 
were starved, fixed and stained to analyze LC3 localization (Fig. 11A). In WT MEFs, 
the typical LC3 recruitment to autophagosomes was observed. By contrast, in Atg5-/- 
MEFs, LC3 had a cytoplasmic localization (Fig. 11A, left images). Next, we analyzed 
the dynamics of LC3 in WT and Atg5-/- MEFs after infection with mCherry-expressing 
sporozoites (Fig. 11A, right images). While LC3 accumulated in the classical pattern 
around the parasite in WT MEFS, in infected Atg5-/- MEFs it stayed in the cytoplasm. 
This suggests that the LC3 recruitment observed in WT cells after sporozoite 
infection is dependent on the typical processing and lipidation of LC3 that is mediated 
by ATG5.  
We next reasoned that if LC3-dependent autophagy is indeed an important 
mechanism by which the host restricts parasite establishment in its cells, infection of 
Atg5-/- MEFs should result in higher parasite counts. Indeed, the Atg5-/- MEF 
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cultures had more than twice as many infected cells than the WT MEF cultures (Fig. 
11B). However, the parasites developing in the Atg5-/- MEFs were significantly 
smaller than the parasites that had escaped elimination and continued to reside in 
the WT MEFs (Fig. 11C). This suggests that host cell autophagy may also have 
beneficial effects for the parasites that manage to escape the first wave of the 
cytosolic immune response. Since we observed that infected cells not only recruited 
LC3 to the PVM but also constantly generated typical autophagosomes (Vid. S10), 
we reasoned that successful Plasmodium parasites may induce and exploit host cell 
autophagy to obtain additional amino acids. To test this possibility, we supplemented 
the medium of sporozoite-infected Atg5-/- cells with additional amino acids. Indeed, 
this rescued the parasite size in these cells (Fig. 11C).  
 
Discussion 
Host cell response against Plasmodium infection. It has become increasingly 
clear that cells try to fight intracellular pathogens by many means.12 Committing 
‘suicide’ by inducing apoptosis is one possibility; another one is to isolate the 
pathogen in a compartment and then specifically eliminate it. The latter mechanism is 
particularly valuable for the host as the infected cell can then introduce pathogen 
peptides into the MHC presentation system.30 Presentation via MHC has the 
additional advantage that it can help to induce a cell-mediated immune response 
against the infected cells.  
Autophagy is an important and well-studied cytosolic immune response. In 
selective autophagy, newly formed membranes surround the pathogen that is to be 
eliminated.12 These membranes are labeled with LC3-II and later fuse with 
lysosomes to form degradative autolysosomes. Aside from selective autophagy, 
recent studies have suggested that there are several other alternative pathways that 
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have the capacity to eliminate pathogens.31,32 Most of such pathways are closely 
related to autophagy and even share the same molecules to execute their tasks. In 
principle, their main role is to isolate the pathogen in a compartment, to label the 
membrane of the pathogen-containing compartment, to direct destructive organelles 
like lysosomes towards these compartments, and finally to fuse these organelles with 
the membrane of such compartments, thereby releasing their degradative content 
into the pathogen’s hosting niche. Many pathogens, including Plasmodium 
sporozoites, enter the cell by invaginating the host cell membrane and forming a 
vacuolar membrane. Thus, they are already in an isolated compartment. It has been 
shown for several invasive bacteria that such already existing compartments can be 
recognized by the host cell and are labeled by LC3-II.9,33,34 We have shown here that 
this also occurs with invading Plasmodium sporozoites. Although the entire 
mechanism for new membrane formation is not needed because the PVM is directly 
labeled, the pathways that result in LC3 processing and lipidation35 still appear to be 
necessary. These pathways include two ubiquitin-like conjugation systems. If one of 
these conjugations systems is blocked or the C-terminus of LC3 is altered, correct 
processing and lipidation will no longer be possible. Indeed, when we expressed the 
GFP-LC3G120A mutant in HepG2 cells and then infected them with mCherry-
expressing parasites, we found that the mutant protein did not incorporate into the 
PVM membrane. Thus, in Plasmodium infection of hepatocytes, like in other 
infections, LC3 must be properly processed and lipidated before it successfully 
incorporates into the PVM. We were also able to assess the functional significance of 
this event by using MEFs in which the Atg5 gene has been deleted.28 In these Atg5-/- 
MEFs, we never observed incorporation of LC3 into the PVM and parasite elimination 
was significantly reduced, confirming that the autophagy-related pathway participated 
directly in parasite control. The fact that more parasites were detected in the 
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autophagy-deficient MEFs than in the autophagy-competent MEFs clearly supports 
the notion that the host cell exerts an active autophagy-related process to eliminate 
viable parasites, rather than the dying parasites simply being removed by autophagy. 
While LC3 incorporation into the PVM appears to be an autophagy-related 
process, it is not a typical selective autophagy since the latter is characterized by the 
formation of new phagophores. Instead, LC3 incorporation to the PVM resembles 
LAP more closely. However, LAP is clearly defined by a certain order of molecular 
events.36 Since the invasion of bacteria and Plasmodium sporozoites are entirely 
different processes, we expected that the molecular events resulting in LC3 
incorporation into the PVM would differ from the events in LAP. Indeed, results from 
our laboratory strongly suggest that LC3 incorporation into the PVM does not depend 
on phosphatidylinositol 3-phosphate and Beclin-1 labeling (data not shown), which 
are hallmarks of LAP.36 
The exclusion of canonical autophagy and LAP suggests that P. berghei-
infected hepatocytes must have an alternative pathway by which LC3 is incorporated 
into a membrane. Similar to selective autophagy, this new pathway appears to be 
initiated by ubiquitination, and subsequent association with the linker protein 
SQSTM1. However, unlike selective autophagy, no new membrane is built around 
the PVM. Instead, ubiquitin, SQSTM1 and LC3-II all appear to be directly 
incorporated into the PVM. The fact that Atg5-deficient MEFs allow ubiquitination but 
not LC3-II incorporation supports the idea that ubiquitination precedes LC3-II 
mobilization, perhaps via SQSTM1, which is incorporated into the PVM with similar 
kinetics as ubiquitin and LC3-II.  
 
Parasite escape from the cytosolic immune response of the host cell.  Although 
our data show clearly that host cells can actively eliminate a considerable number of 
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parasites, more than half of them evade this response. We still do not know why 
some parasites are eliminated and others develop normally. We hypothesize that 
there may be a very fine balance between the parasite and the host cell that 
determines the outcome of the infection. During schizogony, successful parasites 
appear to actively remove LC3 from the PVM and avoid continued attack by 
lysosomes. There are several mechanisms by which the parasite could achieve this. 
First, it could activate a protease that cleaves LC3. One such protease may be the 
host-cell ATG4. This protease executes exactly this function during canonical 
autophagy.37,38 Another option is that the labeled membrane is shed; the time-lapse 
movies provided in this study indeed suggest this (in particular in long-term videos 
S2, S3, and S4). However, this observation needs to be further validated 
experimentally. 
Although it is clear that the parasite has developed strategies that allow it to 
survive within hepatocytes, many aspects remain to be analyzed. It is not known why 
the PV of successfully developing parasites does not acidify, despite fusion of the 
PVM with lysosomes, as shown in this and a previous study.20 One possibility is that 
the PVM contains outward-directed proton pumps. However, this may not be 
necessary considering that the PVM contains pores for the easy uptake of nutrients 
of up to 855 Da,39 and that proton gradients may not be able to form in such an 
environment because they need tight membranes without pores. It has also been 
suggested that the PVM fuses selectively with lysosomes with a mild pH. However, 
how the PVM can select between lysosomes with low and mild pH is not known. It is 
also not clear why we did not detect DQ-BSA in the PV of normally developing 
parasites. If lysosomes fuse with the PVM, it can be assumed that their contents are 
released into the PV. Indeed, it has been shown that gold particles that are taken up 
by the endocytic pathway of infected host cells can be delivered via lysosomes to the 
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PV and even to the parasite cytoplasm.20 However, since we have shown in this 
study that parasites can be isolated and eliminated within autolysosomes, it remains 
to be determined whether the parasites containing gold particles are still viable.  
A recent study showed that in Plasmodium yoelii-infected hepatocytes, the 
phosphorylation of Akt kinase and mTOR is elevated.40 The authors speculated that 
this protects the parasites from host cell autophagy. Moreover, the expression levels 
of typical autophagy marker proteins like LC3 were not increased.40 Transcriptome 
and proteome analysis in earlier reports also failed to detect elevation of autophagy-
related transcripts or proteins in Plasmodium-infected hepatocytes,41,42 which 
strongly suggests that transcription of autophagy genes is at least not enhanced. 
These observations are not contradictory to the data provided in this study. 
Autophagy can be induced at different levels. On one hand, selective autophagy can 
immediately be activated without transcriptional activation because all components 
are already present in the cell.27 Induced autophagy, on the other hand, relies on 
transcriptional activation and the production of new proteins. Our results suggest that 
the new pathway observed in Plasmodium-infected hepatocytes does not depend on 
transcriptional activation of autophagy genes and is thus compatible with the data of 
the study on Plasmodium yoelii-infected hepatocytes described above.40 It now 
remains to be determined how the parasite controls the induced autophagy of the 
host cell.  
 
Canonical non-selective autophagy supports parasite survival and growth. 
Another interesting aspect of Plasmodium infection of hepatocytes was that the 
successful parasites appeared to benefit from host-cell autophagy, as it provided 
them with an additional source of nutrients. During schizont development, many 
autophagic events were observed in infected cells probably because the fast-growing 
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parasite uses amino acids from the host cell. As such, amino acid starvation is a 
strong trigger of canonical non-selective autophagy. In fact our in vivo and in vitro 
data strongly suggest that activation of non-selective autophagy heavily supports 
parasite survival and growth. Starvation-mediated as well as drug-activated 
autophagy resulted in significantly enhanced parasite liver load whereas block of 
autophagy reduced parasite liver load. Nevertheless, we believe that the autophagy 
we observed is restricted to the already existing basal autophagy machinery in 
agreement with observations provided by earlier studies.40-42  
In summary, we suggest that hepatocytes counter Plasmodium parasite 
infection via a novel cytosolic immune reaction, and that the parasite responds by 
manipulating and modulating this host cell response. We believe that other 
intracellular parasites, bacteria and viruses may employ similar mechanisms. How 
this knowledge can be translated into effective treatment strategies against these 
different pathogens remains to be explored. 
 
 
Materials and Methods 
 
Ethics statement. This study was carried out in strict accordance with the guidelines 
of the German Tierschutzgesetz (Animal Rights Laws). Mice were obtained from 
Charles River Laboratories and were between 6 and 10 weeks of age. The protocol 
was approved by the Department of Veterinary Affairs of the Hamburg state 
authorities (Permit Number: FI 28/06). Blood feeding and intravital imaging was 
performed under ketavet/rompun anesthesia, and all efforts were made to minimize 
suffering. For the generation of the PbmCherryhsp70+Luceef1α parasite line Swiss mice 
(OF1 ico, Construct 242; 6 weeks old; 25–26 g; Charles River) were used. All animal 
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experiments to generate and characterize this line were performed at the LUMC and 
approved by the Animal Experiments Committee of the Leiden University Medical 
Center (DEC 12042). The Dutch Experiments on Animals Act was established under 
European guidelines (EU directive no. 86/609/EEC regarding the Protection of 
Animals used for Experimental and Other Scientific Purposes). 
 
Parasites 
P. berghei-ANKA lines were used to infect mice and cell cultures. P. berghei-
mCherry43 and P. berghei-GFP44 constitutively express fluorescent proteins that 
localize to the cytosol of the parasite. P. berghei-Exp1-mCherry45 express the PVM 
marker protein Exp1 fused to mCherry under the liver stage specific promoter 
(PBANKA_100300)  at the parasite PVM. 
The PbANKA-230p GIMO mother line (GIMOPbANKA; line 1596cl1) which contains the 
positive-negative selection marker (SM) cassette, a fusion gene of hdhfr (human 
dihydrofolate reductase; positive SM) and yfcu (yeast cytosine deaminase and uridyl 
phosphoribosyl transferase; negative SM) under control of the constitutive eef1a 
promoter, stably integrated into the neutral 230p locus (PBANKA_030600) through 
double cross-over recombination.46 GIMOPbANKA  is a reference P. berghei ANKA line 
that is used to rapidly introduce transgenes without drug-resistance markers. 
 
Generation and analysis of the reporter line PbmCherryhsp70+Luceef1α 
Construct pL1720 was made for generation of reporter line mCherryhsp70+Luceef1α that 
expresses mCherry reporter under control of the hsp70 (PBANKA_071190) 5’- and 
3’-regulatory sequences and luciferase under the control of the ee1fα  
(PBANKA_113330) 5’-promoter/regulatory sequences and the pbdhfr/ts 
(PBANKA_071930) 3’-regulatory sequences. This construct was used to target the 
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GIMOANKA mother line using the ‘gene insertion/marker out’ (GIMO transfection) 
procedure.46 Construct pL1720 was made as follows: first the selectable marker (SM) 
cassette from pL1661 (containing both 5’hsp70 and 
3’hsp70 sequences, tgdhfr/ts SM, and 230p targeting regions) was removed by 
digesting the plasmid with SnaBI (Roche, 10997480001) and SbfI (New England 
Biolabs; R06425) followed by treatment of the DNA fragment with Klenow (Roche, 
11008404001) and re-ligation resulting in a plasmid that contains only the 5’hsp70-
3’hsp70 sequences and the 230p (PBANKA_030600) targeting regions; the mCherry 
coding sequences (excised from pL0047 which contains the 5’pbeef1α-mCherry-
3’pbdhfr cassette) was then introduced into this plasmid using sites BamHI (Roche, 
10220612001) and NotI (Roche, 11014706001). Next a luciferase expression 
cassette (5’pbeef1a-LucIAV-3’pbdhfr) excised from pL1098 using KpnI (Roche 
11198939001) and AflII (Roche, 11198939001) was introduced into this vector using 
the same restriction sites. This final construct, pL1720, therefore contains the 
5’hsp70-mCherry-3’hsp70 and 5’pbeef1a-LucIAV-3’pbdhfr expression cassettes 
and 230p targeting sequences but no SM. This construct was linearized by digesting 
with SacII (Roche, 11117807001) before transfection. The linear DNA construct was 
introduced into GIMOANKA parasites using standard methods of GIMO-transfection.46 
Transfected parasites were selected in mice by applying negative selection by 
providing 5-fluorocytosine (5-FC) (Sigma, F7129-5G) in the drinking water of mice.47 
Negative selection results in selection of parasites where the hdhfr::yfcu SM in the 
230p locus is replaced by the mCherry reporter-cassette. Selected transgenic 
parasites (mCherryhsp70) were cloned by the method of limiting dilution.48 Correct 
integration of the constructs into the genome of mCherryhsp70 parasites was analysed 
by diagnostic PCR-analysis on gDNA and Southern analysis of pulsed field gel (PFG) 
separated chromosomes as described.49 Growth of blood stages (asexual 
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multiplication rate) of mCherryhsp70 parasites was determined during the cloning 
period as described50 Gametocyte production (gametocyte conversion rate) was 
determined as previously described.51  
 
Cell culture and infection of HepG2, MEF cells and primary hepatocytes. Human 
hepatoma cells (HepG2) were provided by the European Collection of Cell Cultures 
(ECACC) and were maintained in Minimum Essential Medium (MEM) with Earle’s 
salts supplemented with 10% fetal calf serum (FCS), 100 U penicillin, 100 µg/ml 
streptomycin and 2 mM L-glutamine (all from PAA Laboratories, E15-024, A15-101, 
P11-010, M11-004). WT and Atg5-/- murine embryonic fibroblasts (MEF, kindly 
provided by N. Mizushima) were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% FCS, 100 U penicillin, 100 µg/ml streptomycin, 2 
mM L-glutamine and 1x non-essential amino acids (NEAA) (all from PAA 
Laboratories, E15-009, A15-101, P11-010, M11-004, M11-003). For the rescue 
experiments, MEFs were cultured in MEM supplemented as described above with or 
without extra amino acids (PAA Laboratories, M11-002). The cells were cultured at 
37°C and 5% CO2 and were split using Accutase (PAA Laboratories, L11-007). 
Primary mouse hepatocytes were isolated by using the protocol described by 
Wenshuo Zhang (http://www.mouselivercells.com) with modifications. Briefly, the liver 
of a freshly euthanized mouse was perfused via the portal vein with Hepes Buffer 
(137 mM NaCl (Sigma-Aldrich, S9888-1KG) , 2.68 mM KCl (Fluka Chemie AG P9541-
1KG), 10 mM Hepes, 0.7 mM Na2HPO4,(Fluka Chemie AG, 71633-250G) pH 7.6, 100 
U penicillin, 100 µg/ml streptomycin, for 10 minutes followed by collagenase IV (100 
U/ml) (Worthington Biochemical Corporation, LS004188) in William’s Medium E 
(Bioconcept, 1-48F01-l) containing 2 mM L-glutamine for 10 minutes. The perfusate 
was drained out of the body via the inferior vena cava, which was cut immediately 
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after starting perfusion. During both perfusion periods, the inferior vena cava was 
clamped every two minutes for 10 seconds to inflate the liver. The digested liver was 
then excised rapidly, the liver capsule was disrupted, and the hepatocytes were 
released by gently shaking the digested liver into William’s Medium E with 2 mM L-
glutamine. The cells were washed three times by 50 g centrifugation in William’s 
Medium E with 2 mM L-glutamine for 2 minutes. Viability was checked by using the 
trypan blue exclusion method. Between 100,000 and 200,000 cells were seeded onto 
glass bottom dishes (MatTek corporation, P35G-1.5-20-C) in growth medium 
(William’s Medium E, 2 mM L-glutamine, 10% FCS, 100 U penicillin, 100 µg/ml 
streptomycin). The growth medium was replaced 3 to 5 hours after isolation. The 
cells were cultured at 37ºC and 5% CO2. 
 When required, cells were treated with 10 µg/ml DQTM Red BSA (DQ-BSA red, 
Molecular Probes, D12051) overnight or 75 nM LysoTracker Red DND-99 (Molecular 
Probes, L-7528) for 10 minutes. P. berghei-ANKA lines were used to infect mice and 
cell cultures. P. berghei WT does not express any fluorescent protein. P. berghei-
mCherry and P. berghei-GFP are phenotypically not different from WT parasites 
apart from the fluorescence. Sporozoites were prepared from the salivary glands of 
infected female Anopheles stephensi mosquitoes and were incubated with the host 
cells for 2-4 hours. To infect MEFs, the cell and sporozoite mixture underwent an 
additional centrifugation step (500xg for 5 minutes) during the incubation. After 
washing, the infected cells were incubated in the medium described for each host cell 
type above, which was supplemented with 2.5 µg/ml Amphotericin B (PAA 
Laboratories, P11-001).  
 
Plasmids. The plasmid EGFP-LC3 was kindly supplied by Jonathan C. Howard, 
Cologne, Germany and the LAMP1-GFP construct was a kind gift from John Brumel. 
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pmRFP-LC3 (plasmid 21075)52 and GFP-Ubiquitin (plasmid 11928)53 were obtained 
from Addgene (Cambridge, MA, USA). The plasmid Cathepsin D-mRFP was kindly 
provided by François Darchen, Paris, France.22 All galectin constructs were kindly 
provided by Felix Randow, Cambridge, UK. To generate the plasmid EGFP-LC3G120A, 
the G120A mutation was introduced into the LC3 gene in the plasmid EGFP-LC3 by 
using the 5’-GGGCTCGAGATGCCGTCCGAGAAGACC-3’ and 5’-
GGGGTCGACTTACACAGCCATTGCTGTCGCGAATGTCTC-3’ primers and the 
restriction enzymes XhoI (New England Biolabs, R0146S) and SacI (New England 
Biolabs, R0156S). 
 
Transfection of HepG2 and MEF cells.  
1x106 cells were pelleted by centrifugation. After resuspension in Nucleofector V 
solution (Lonza, VVCA-1003) for HepG2 cells or MEF1 solution for MEFs (Lonza, 
VPD-1004), the cells were transfected with 3 µg of either GFP-LC3 DNA, RFP-LC3 
DNA, Cathepsin D-mRFP DNA, or GFP-Ubiquitin DNA by using a Nucleofector 
transfection device (program T-028 for HepG2 cells and T20 for MEFs) according to 
the manufacturer’s instructions. The cells were then seeded onto glass bottom dishes 
for live cell imaging or onto 24 well plates on cover slips for IFA analysis.  
 
Indirect immunofluorescence analysis. After the indicated time points, the infected 
cells were fixed in 4% paraformaldehyde in PBS for 20 minutes at room temperature. 
Subsequently, they were either incubated in ice-cold methanol for 10 minutes at -
20ºC (for the anti-LAMP1 and -UIS4 antibodies) or permeabilized by using 10 µg/ml 
Digitonin (for the anti-LC3 antibody) (Sigma-Aldrich, D141-100MG)  or 1% Triton X-
100 (Fluka Chemie, T8787-250ML)  in 10% FCS/PBS (for the anti-ubiquitin and anti-
SQSTM1 antibodies). After washing with PBS, the non-specific binding sites were 
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blocked by incubation in 10% FCS/PBS for 1 h at room temperature. The primary 
antibodies were diluted in 10% FCS/PBS and then added to the culture. After 1 h at 
room temperature, the cells were washed with PBS. For detection, the cells were 
incubated with secondary antibodies for 30-60 minutes at ambient temperature. The 
nuclei were stained with 1 µg/ml DAPI (Invitrogen, D-1306). The cells were washed 
again with PBS and mounted on microscope slides with Dako Fluorescent Mounting 
Medium (Dako, S3023). For live imaging, the nuclei were stained with Hoechst 33342 
(Sigma-Aldrich, B2261). 
 The primary antibodies that were used were mouse monoclonal anti-GFP (BD 
Biosciences, 565197), rat monoclonal anti-RFP (Chromotek, 5f8), mouse 
monoclonal anti-LC3 (MBL international, M152-3), rabbit polyclonal anti-UIS4 (kindly 
provided by P. Sinnis), chicken polyclonal anti-EXP1 (Heussler Lab, BNITM, 
Hamburg, Germany), mouse monoclonal anti-ubiquitin (Enzo life science, BML-
PW8810, clone FK2), rabbit monoclonal anti-SQSTM1/SQSTM1 (MBL international, 
PM045),  and mouse monoclonal anti-hLAMP1 (Developmental Studies Hybridoma 
Bank, H4A3). Secondary antibodies were anti-rabbit Alexa Fluor® 594 (Invitrogen, 
A21207), goat anti-rabbit Alexa Fluor® 488 (Invitrogen, A11034), anti-mouse Alexa 
Fluor® 488 (Life technologies, A21202), anti-mouse Alexa Fluor® 594 (Invitrogen, 
A11032), anti-rat Alexa Fluor® 594 (Invitrogen, A11007), anti-rat Alexa Fluor® 488 
(Invitrogen, A21208), and anti-chicken Alexa Fluor® 594  (Invitrogen, A11042). 
 
Live cell imaging and time lapse microscopy. Confocal laser line scanning (CLS) 
was performed with a Zeiss Observer Z1 inverted microscope integrated into a laser-
scanning microscope (LSM5). Images were acquired by using a Zeiss 63 x Plan-
Apochromat 1.4 oil objective and the Zeiss Efficient Navigation 2008 and 2009 
 29
software. During imaging, the cells were maintained in a CO2 (5%) incubator at 37ºC. 
Images of fixed cells were generated by a confocal laser point scanning microscope 
(Olympus FV1000 confocal microscope) or by using the Leica DM12000B widefield 
epifluorescence microscope (Wetzlar, Germany). Contrast and brightness levels 
were optimized by using either the Zeiss Efficient Navigation 2009 (Jena, Germany), 
the ImageJ (NIH, USA) software, or Adobe Photoshop. Images were processed as a 
whole. 
To monitor parasite development, the size of parasites was determined by 
using the density slice module of the OpenLab software version 5.0.2 or ImageJ.  
Intravital microscopy was performed as previously described54 by using the 
LSM 510 Zeiss microscope in the LSM 5 live mode. Images were acquired by CLS 
microscopy using a Zeiss Plan Apochromat 63x/1.40 oil DIC M27 objective and the 
Zeiss LSM 5 Duo Release Version 4.2. GFP-LC3 mice (kindly provided by K. 
Mizushima11) were infected with mCherry-expressing parasites and intravital imaging 
of an infected liver lobe of an anesthetized mouse was performed at the indicated 
time points. Image processing was performed by using ImageJ. 
 
Super Resolution Microscopy. For dual-color stimulated emission depletion 
(STED) microscopy, hepatocytes infected with P. berghei sporozoites were fixed 24 
h.p.i. with 4% (w/v) paraformaldehyde in PBS followed by 15 min permeabilization in 
0.1% Triton-X and 1 h incubation in 10% FCS/PBS blocking buffer. Cells were 
stained over night by 4°C with 10 µg/ml of anti-LC3 (MBL international, M152-3) and 
anti-UIS4 (kindly provided by Photini Sinnis) and labeled with 2 µg/ml Oregon Green-
488 goat anti-mouse IgG (H+L) (Molecular Probes, Invitrogen, O-6380) and Abberior 
STAR 440SX goat anti-rabbit IgG (Abberior GmbH, 2-0012-003-4) at room 
temperature for 1 h. Samples were embedded in Mowiol® 4-88 (Roth, 0713.1) 
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containing 2.5% DABCO® (Roth, 0718.1) antifade.  
Microscopy was conducted on the Leica TCS SP8 inverted microscope equipped 
with gated STED system and a HC PL APO STED WHITE 100x/1.4 oil immersion 
objective (Leica Microsystems, Wetzlar, Germany). Depletion was performed with a 
592 nm depletion laser and images acquired with a time delay of T g = 0.5 ns. Z-
Stacks were obtained with increments of 0.22 µm and subsequently deconvolved 
with the Huygens STED Deconvolution software (Scientific Volume Imaging, 
Hilversum, Netherlands) and further processed with the image analysis software 
FIJI55. 
 
Electron microscopy. Infected HepG2 cells were FACS-sorted to enrich for infected 
cells and seeded on Thermanox coverslips. At 48 hours post-infection, the cells were 
washed twice with PBS, fixed with 2% glutaraldehyde (Electron Microscopy 
Sciences, 16210) in sodium-cacodylate buffer, pH 7.2 and postfixed with 1% osmium 
tetroxide (Sigma-Aldrich, 201030-1G). The samples were then dehydrated by using a 
series of increasing ethanol concentrations and propylene oxide. The cells were 
embedded in an epoxy resin (Epon). Ultrathin sections were made by using Ultra Cut 
E (Reichert/Leica) and stained with uranyl acetate and lead citrate. The sections 
were then examined with a Tecnai Spirit (Fei) at an acceleration voltage of 80 kV. 
 
Quantification of viable P. berghei parasites. HepG2 cells seeded in 96-well 
μClear® plates (Greiner-Bio-one, 655097) were infected with P. berghei expressing 
mCherry. Two hours post-infection, excess parasites were washed away twice with 
medium. Rabbit polyclonal anti-CSP antibody (diluted 1:1000) was added to the 
medium and incubated for 1 h to eliminate extracellular parasites. Cells were washed 
and the plate was imaged with an IN Cell Analyzer 2000 automated cell imaging 
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system (GE Healthcare Life sciences, Glattbrugg, Switzerland) (10× objective, 9 
fields/well) at 3.5, 9, 24, 33 and 48 h post-infection. The mCherry signal was detected 
using excitation and emission filters for TexasRed (emission: 579 nm; excitation: 605 
nm). The exposure time was 15–30 ms (30 ms for the 3.5 h and 9 h time points and 
15 ms for the later time points). IN Cell Developer Toolbox 1.7 was used to analyze 
the acquired images. Intensity segmentation was used to identify P. berghei 
mCherry. A post-segmentation process (Sieve) was used to exclude 10 μm2 objects 
(3.5–24 h) and 20 μm2 objects (33–48 h). The output was the number of parasites 
per well in the 9 fields. The results of quadruplicate experiments are displayed 
graphically (the number of parasites per well at 3.5 h was set at 100%). 
 
Quantification of autophagy and degradation markers. HepG2 cells were infected 
with P. berghei sporozoites and labeled with antibodies specific for different 
degradation markers, LysoTracker, or DQ-BSA before being monitored by 
microscopy. Quantification was performed visually by counting the parasites that 
were stained strongly or weakly by the dye or antibody. For LysoTracker red-, and 
DQ-BSA red-stained HepG2 cells, and HepG2 cells transfected with cathepsin D-
RFP, a strong association was deemed to be the presence of 10 or more positive 
vesicles in the immediate proximity of the parasite. Fewer than 10 vesicles around 
the parasite was defined as a weak association. In infected HepG2 cells that were 
transfected with ubiquitin-GFP or LC3 or stained with anti-SQSTM1 antibody or anti-
LAMP-1 antibody, if the signal covered more than 30% of the proximity of the 
parasite, the association was considered to be strong. If less than 30% of the 
parasite was covered with these signals, it was deemed to be a weak association. 
Arrested parasites were those parasites with clear growth impairment, as indicated 
by their small size. 
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Preparation of P. berghei parasites and mice for bioluminescence imaging 
For bioluminescence imaging of liver stage development, 1x105 P. berghei 
sporozoites were collected from salivary glands of infected Anopheles stephensi 
mosquitoes and injected intravenously into female Balb/c mice 8-10 weeks of age. 
For starvation assays, mice were separated into a group feeding ad libidum, a 30h 
starvation group after infection, and a group starved for 12h prior to infection followed 
by 18h post-infection. For autophagy inhibition and induction assays, mice were 
separated into an untreated control group, a group treated with 50mg/kg chloroquine 
(Sigma-Aldrich, C6628) at 12, 24 and 36hpi; a group treated with 2.5mg/kg of 
rapamycin (Enzo Life Sciences, BML-A275-0005) at 12, 24, and 36hpi; a pre-treated 
group, treated with 50mg/kg chloroquine 2h prior to sporozoite injection, and then 12, 
24 and 36hpi; and a pre-treated group, treated with 2.5mg/kg rapamycin 12h prior to 
sporozoite injection followed by consecutive treatments at 12, 24 and 36hpi.  
Chloroquine was diluted in 0.9% NaCl to a final concentration of 20mg/ml. 
Rapamycin was dissolved in 100% ethanol to a final concentration of 10mg/ml. For 
luminescence assays, rapamycin was dissolved in a solution medium consisting of 
5% PEG-400 (Sigma-Aldrich, 81170), 5% Tween 80 (Sigma-Aldrich, P4780-500ML), 
and 4% ethanol (Merk Millipore, 100983). Dilutions of both drugs were prepared at 
the time of administration. Separate control mice were injected with solution media to 
exclude the potential of artificial effects in luminescence observations.  
 
Real time in vivo bioluminescence imaging of liver stage development 
Luciferase activity in all mouse groups was determined by full body imaging of mice 
using an IVIS Lumina II imager (Caliper Life Sciences, USA). Infected mice under the 
various fasting and treatment conditions were anaesthetized using the isofluorane 
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anaesthesia system (XGI-8, Xenogen, Caliper Life Sciences, USA). Measurements 
were performed at various time points post-infection including 12, 24, 36, 44, 56 and 
60h, and days 3 and/or 6 post-sporozoite injection. For firefly luciferase quantitation, 
anaesthetized mice were injected with 100ul of RediJect D-Luciferin (30mg/ml; Perkin 
Elmer, 760504) intraperitoneally. Measurements were performed 7-10 minutes after 
injection of the substrate. Imaging was acquired with a 10cm FOV, medium binning 
factor, and exposure time of 3 minutes. Quantitative analysis was performed using 
the Living Image 4.1 software.  
 
Staining and histology of liver tissue sections 
Histology sections were generated for measurement of size and numbers of 
parasites at 40h post-infection in the following sets of mice: control, fasting for 24hpi, 
fasting for 36h post infection, pre-fasting for 12h and 24h post infection, Rapamycin-
treated, and chloroquine-treated. 3 Balb/c and 3 C57B/6 mice were used per 
condition, and infected with varying doses of sporozoites, ranging from 5x104 to 
2x105. At 40hpi, mice were euthanized, perfused with 5ml of 4% PFA in PBS, and 
livers removed. Both complete livers lobes were further stored in 2% PFA in PBS for 
a further 12h, and then paraffin-embedded. 10 x 50μm sections of both lobes of each 
animal from various tissue depths were obtained, and stained with hematoxylin and 
eosin (H&E). Sections were thoroughly analyzed using a Leica DM 5500 B Upright 
widefield epifluorescence microsope using a 40x objective for general imaging, and a 
100x1.6 oil objective for detailed analysis. Images were obtained using the Leica LAS 
AF Software, and size measurements performed in ImageJ/Fiji.     
 
 
Statistical analysis. Two groups were compared by using a two-tailed, unpaired 
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Student’s t-test. All statistical analyses were performed by using Prism version 4.0a 
for Macintosh, GraphPad Software, San Diego, California, USA. p values less than 
0.05 were considered to indicate statistical significance. 
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Figure legends 
 
Figure 1. LC3-II is recruited to the vicinity of Plasmodium parasites in primary 
mouse hepatocytes. (A) Primary mouse hepatocytes were freshly isolated, seeded 
on coverslips, and infected with P. berghei that expressed mCherry fluorescent 
protein (PbmCherry). The infected cells were fixed at different developmental stages 
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and stained with an anti-LC3 antibody and the DNA dye DAPI. Labeled scale bars 
are included at the bottom-right of the images. (B) In vivo LC3 dynamics in 
Plasmodium berghei-infected cells. A GFP-LC3-expressing mouse (green) was 
infected with mCherry-expressing P. berghei parasites (red) and analyzed by 
intravital imaging at different developmental stages, as indicated. (C) Intravital 
imaging of the same mouse that shows a dying parasite at the late developmental 
stage. The dispersed parasite vesicles show a transient but strong association with 
GFP-LC3. Scale bars: 10 µm. See also video S1. 
 
 
Figure 2. In vitro LC3 dynamics in Plasmodium berghei-infected cells.  (A) 
HepG2 cells were transfected with a plasmid encoding GFP-LC3, infected with P. 
berghei sporozoites expressing mCherry protein, and monitored at different phases 
of development. Spz: invaded sporozoites at 4 hours post-infection; e-schz: early 
schizont at 24 hours post-infection; l-schz: late schizont at 48 hours post-infection; 
cyt: cytomere stage at 56 hours post-infection. Representative images are shown 
below the graph. The infected host cells harboring LC3-associated parasites, 
vesicular LC3, or cytoplasmic LC3 were counted and expressed as percentages. 
Scale bars: 10 µm. (B) To study the dynamics of parasite elimination during liver-
stage infection, HepG2 cells were seeded in 96-well plates and infected with 
mCherry-expressing parasites. To eliminate the extracellular parasites, the infected 
cells were treated with an anti-CSP antiserum. The parasites were then counted by 
using an IN Cell analyzer at the indicated time points. The average number of 
invaded parasites at the sporozoite stage (i.e. 3.5 hours post-infection) was 
considered to be 100%. (C) Electron microscopic analysis of P. berghei-infected cells 
during sporozoite transformation and early schizogony. The overview and the 
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magnifications clearly demonstrate that apart from the parasite membrane (PM) and 
the parasitophorous vacuole membrane (PVM), no other surrounding membranes are 
visible. The insets are magnifications of the areas of interest, including PM and PVM. 
Scale bars of the left image: 200 nm, inset: 100 nm. Scale bars of the right image: 2 
µm, inset 100 nm. 
 
Figure 3. Host cell LC3 incorporation into the parasitophorous vacuole 
membrane (PVM). (A) LC3-RFP-expressing hepatocytes infected with a 24 h liver 
schizont co-stained with anti-LC3 (green) and the PVM marker UIS4 (red). STED 
microscopy was perfomed and z-Stacks were obtained with increments of 0.22 µm 
and subsequently deconvolved. 3D-projection of the PVM shows a direct 
incorporation of the host cell autophagy marker LC3-II. Quantification of the 
colocalisation applying the Pearson’s coefficient revealed a correlation value of  = 
0.71. The inset shows a magnification of the PVM with strong LC3 incorporation. 
Scale bar: 2 µm (B) GFP-LC3-transfected HepG2 cells were infected with 
Plasmodium berghei sporozoites, fixed at different time points after infection, and 
stained with antiserum against the PVM marker protein UIS4 (red). To detect GFP-
LC3 localization, the cells were also stained with an anti-GFP antibody (green). For 
the merged picture, the DNA stain with DAPI (blue) was included. Scale bars: 10 µm. 
(C) LC3 persistence in the PVM during schizogony associates with impaired parasite 
growth. The immunofluorescence analysis images show neighboring infected cells 
harboring schizonts, one of which is GFP-LC3-positive and small (S). The second is 
GFP-LC3-negative and larger (L). Staining was performed as described in B. Scale 
bars: 10 µm. (D) The sizes of the LC3-positive and -negative parasites 48 hours post-
infection (late schizogony) were measured and compared statistically. p <0.0001.  
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Figure 4. The PV is not a destructive vacuole. (A) HepG2 cells infected with 
Plasmodium berghei sporozoites expressing the GFP fluorescent protein were 
labeled with LysoTracker for 10 minutes. They were then monitored by live 
microscopy at different developmental stages. At the sporozoite stage, there was 
marked accumulation of LysoTracker-positive vesicles around the parasite, which 
met the criteria for strong association (the presence of >10 LysoTracker-positive 
vesicles around the parasites was deemed to indicate a strong association. A weak 
association was <10 vesicles). The parasites with strong and weak associations were 
counted and expressed as percentages. Standard deviations are depicted. DNA was 
stained with Hoechst 33342. Sporozoite (spz) p = 0.0148.  Early schizont (e-schz) p = 
0.0015. Late schizont (l-schz) p = 0.0011. (B) HepG2 cells infected with mCherry-
expressing P. berghei parasites were fixed at different time points and stained with 
an antibody specific for LAMP1. DNA was stained with DAPI. Scale bars: 10 µm. 
Stained cells were then monitored by live microscopy at different stages of parasite 
development. At the sporozoite stage, marked accumulation of LAMP1-positive 
vesicles around the parasite was observed. It was deemed to be a strong association 
if more than 30% of the parasite was covered by anti-LAMP1 antibody. The parasites 
with strong and weak associations were counted and expressed as percentages. 
Each bar indicates the average of 3 independent experiments. Standard deviations 
are depicted. p < 0.001 (spz), p < 0.001 (e-schz), p < 0.001 (l-schz). 
 
Figure 5. Autophagic markers label arrested parasites. (A) HepG2 cells infected 
with fully virulent Plasmodium berghei-GFP sporozoites were labeled with 
LysoTracker-red for 10 minutes. At 48 hours post-infection, the cells were monitored 
by live microscopy. LysoTracker-positive vesicles around the parasites were counted 
and scored as strong or weak associations as described in Fig. 4. The strongly and 
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weakly associated parasites were then counted and expressed as percentages. Each 
bar indicates the average of 3 independent experiments. Standard deviations are 
depicted. DNA was stained with Hoechst 33342. Scale bars: 10 µm. Arrested p = 
0.0298. Developed p = 0.0011. (B) HepG2 cells infected with mCherry-P. berghei 
sporozoites were fixed 48 hours post-infection and stained with an antibody specific 
for LAMP1. DNA was stained with DAPI. Scale bars: 10 µm. The association of 
LAMP1-positive vesicles with the parasites was scored as strong or weak as before 
(Fig. 4B). The strongly and weakly associated parasites were then counted and 
expressed as percentages. Each bar indicates the average of 3 independent 
experiments. Standard deviations are depicted. p = 0.0023 (arrested), p = 0.002 
(developed).  
 
Figure 6. Ubiquitination and SQSTM1 labeling during early parasite 
development. (A) GFP-ubiquitin (green)-transfected HepG2 cells were infected with 
mCherry-P. berghei sporozoites (red) and monitored by live microscopy at different 
developmental stages. Each image depicts the main phenotype quantified at the 
indicated developmental stage. Scale bars: 10 µm. Quantification was performed 
visually by counting the parasites that associated strongly or weakly with ubiquitin. If 
more than 30% of the parasite’s periphery was covered with ubiquitin-positive 
signals, the parasite was considered to be strongly associated. If less than 30% of 
the parasite’s periphery was covered, the parasite was considered to be weakly 
associated. Each bar indicates the average of 3 independent experiments. Standard 
deviations are depicted. Sporozoite (spz) p = 0.002. Early schizont (e-schz) p = 
0.0037. Late schizont (l-schz) p < 0.001. (B) HepG2 cells infected with mCherry-
expressing P. berghei sporozoites were fixed at different developmental stages and 
stained with an antibody specific for SQSTM1 (green). DNA was stained with DAPI. 
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Scale bars: 10 µm. Quantification of SQSTM1 signals was performed as described 
above for ubiquitin signals. Each bar indicates the average of 3 independent 
experiments. Standard deviations are depicted. Spz p < 0.001. E-schz p = 0.0021. L-
schz p = 0.042. (C) Atg5 WT and Atg5-/- cells transfected with GFP-Ubiquitin plasmid 
were infected with mCherry-expressing Plasmodium sporozoites. Live microscopy 
was performed at 6 hours post infection. Scale bars correspond to 10 µm.  
 
Figure 7. Colocalization of ubiquitin, SQSTM1 and LC3 in infected cells during 
parasite development. (A) GFP-Ubiquitin and RFP-LC3 double-transfected HepG2 
cells were infected with wild type Plasmodium berghei sporozoites and monitored by 
live microscopy at different developmental stages. The sporozoites are labeled by 
complete colocalization of ubiquitin and LC3, which is lost at later time points. DNA 
was stained with Hoechst 33342. (B) GFP-LC3 (green)-expressing HepG2 cells were 
infected, fixed at different developmental stages, and stained with an antibody 
specific for SQSTM1 (red). DNA was stained with DAPI (blue). Scale bars: 10 μm. 
 
Figure 8. Persistence of ubiquitination and SQSTM1 in arrested parasites. (A) 
GFP-Ubiquitin-transfected HepG2 cells infected with mCherry-expressing P. berghei 
sporozoites were monitored by live microscopy 48 hours post-infection. Scale bars: 
10 µm. The strength of ubiquitin-positive staining around the parasite was scored as 
described for ubiquitin in the legend to Figure 7A. Each bar indicates the average of 
2 independent experiments. Standard deviations are depicted. p < 0.0001. (B) 
HepG2 cells were infected with mCherry-expressing P. berghei sporozoites, fixed 48 
hours post-infection, and stained with antibodies specific for SQSTM1. DNA was 
stained with DAPI. Scale bars: 10 µm. The strength of SQSTM1-positive staining 
around the parasite was scored as strong or weak as described for ubiquitin in the 
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legend of Figure 7A. Each bar indicates the average of 2 independent experiments. 
Standard deviations are depicted. Arrested p = 0.0177. Developed p = 0.042. 
 
Figure 9. Assessment of the effect of starvation on parasite liver-stage 
development by in vivo bioluminescence. Balb/c mice were infected by 
intravenous (i.v.) injection of 1x105 PbmCherryhsp70+Luceef1α sporozoites. Mice were 
divided into 3 groups: a control group feeding ad libidum, a group of mice fasting 12h 
prior to infection, and 18h post-infection, and a group of mice fasting for 30h following 
infection. (A) parasite development was assessed by whole body luminescence at 
the indicated time-points (hours post-infection; hpi) in mice. Representative images of 
one mouse per group are shown. (B) ROI measurements for the liver area of all mice 
(n=9) were recorded as photons per second per area (photons/s/cm2) for firefly 
luciferase.  (C) Balb/c and C57B/6 mice were infected with 2x105 sporozoites, and 
divided into a control group, or groups fasted for 24 or 36h. For all mice, livers were 
removed at 40hpi for histology analyses. Sections were stained with H&E, and 
parasite numbers and sizes quantified. Parasite sizes (C) and numbers (D) are 
expressed as percentage to the control. Mean number and parasite sizes of control 
mice were set as 100%. Experiments were repeated 3-5 times (error bars show SD; * 
p=0.05; **p=0.01; ***p<0.001). 
 
 
Figure 10. Assessment of the effect of autophagy induction and inhibition on 
parasite liver-stage development by in vivo bioluminescence. Balb/c mice were 
infected by intravenous (i.v.) injection of 1x105 PbmCherryhsp70+Luceef1α sporozoites. 
Mice were divided into: a control group untreated; a control group injected with 
solution media only; a group treated with rapamycin 12 and 24hpi; a group pre-
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treated with rapamycin 12h prior to infection, and 12hpi; a group treated with 
chloroquine 12 and 24hpi; a group pre-treated with chloroquine 12h prior to infection 
and 12hpi (A) parasite development was assessed by whole body luminescence at 
the indicated time-points (hours post-infection; hpi) in mice. Representative images of 
one mouse per group are shown. (B) ROI measurements for the liver area of all mice 
(n=15) were recorded as photons per second per area (photons/s/cm2) for firefly 
luciferase. Balb/c and C57B/6 mice were infected with 5x104, 1x105, and 2x105 
sporozoites. Histology sections were obtained from infected mice under 3 conditions, 
namely untreated controls, rapamycin-treated mice, and chloroquine-treated mice. 
Livers of all mice were removed 40hpi, paraffin-fixed, H&E-stained and analyzed. 
Parasite sizes (C) and numbers (D) were quantified for the 3 groups. Average 
number and parasite sizes of control mice were set as 100%. Parasite numbers and 
sizes of rapamycin- and chloroquine-treated mice are expressed as percentage of 
controls. Experiments were repeated in triplicate (error bars show SD;  
* p=0.05; ** p=0.01; ***p<0.001; for (B) for simplification * denotes p-value is 
significant; details of significance are shown in figure S9).  
 
Figure 11. Parasite development after host cell autophagy is blocked. (A) Wild-
type (WT) and Atg5-/- murine embryonic fibroblasts (MEFs) were incubated in 
starvation media (EBSS) for 2 hours or maintained in normal media (left panels) 
before they were fixed and stained then and cells were stained with a monoclonal 
anti-LC3 antibody, and analyzed by IFA. In subsequent experiments, WT and Atg5-/- 
MEFs were infected with mCherry-expressing Plasmodium berghei (right panels). 
The infected cells were fixed 2 hours post-infection. Then, cells were stained with a 
monoclonal anti-LC3 antibody, and analyzed by IFA. Scale bars: 10 µm. (B) WT and 
Atg5-/- MEFs were infected with GFP-expressing P. berghei and fixed 48 hours post-
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infection. The total parasites were counted and depicted in the figure. Each bar 
represents the average of three independent experiments. The standard deviation is 
indicated. p = 0.0091. (C) WT and Atg5-/- MEFs were infected with P. berghei 
parasites. In the Atg5-/- cells, the medium was either supplemented with additional 
amino acids (Atg5-/- +aa) or left untreated (Atg5-/-). Parasites sizes were measured 
48 hours post-infection. ***p <0.0001. ns, not significant. 
 
 
Supplementary figures 
 
Figure S1. LC3 must be correctly processed and lipidated before it can 
accumulate around the parasite. (A) HepG2 cells were transfected with either 
GFP-LC3 or (B) the GFP-LC3G120A mutant, which does not undergo LC3 processing 
and lipidation. The transfected cells were then infected with Plasmodium berghei 
parasites expressing mCherry protein and analyzed at different developmental 
stages by live microscopy. DNA was stained with Hoechst 33342. Scale bars: 10 µm. 
 
Figure S2. The parasitophorous vacuole has a non-degradative character. (A) 
HepG2 cells were transfected with cathepsin D-RFP (CathD-RFP) and infected with 
Plasmodium berghei sporozoites expressing GFP. The infected cells were monitored 
by live microscopy at different developmental stages. DNA was stained with Hoechst 
33342. Accumulation of 10 or more cathepsin D-positive vesicles in the immediate 
proximity was considered to indicate a strong association. Fewer than 10 vesicles 
was considered to indicate a weak association. Each bar indicates the average of 3 
independent experiments (n = 50 cells per experiment). p = 0.0067 (spz), p = 0.0074 
(e-schz), p = 0.00194 (l-schz). DNA was stained with Hoechst 33342. (B) HepG2 
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cells incubated with DQ-BSA red overnight were infected with GFP-expressing P. 
berghei parasites and analyzed at different stages of parasite development by live 
microscopy. DNA was stained with Hoechst 33342. Scale bars: 10 µm. Quantification 
and statistical evaluation was performed as described in A. Each bar indicates the 
average of 3 independent experiments (n = 50 cells per experiment). p = 0.0463 
(spz), p = 0.0334 (e-schz), p = 0.0015 (l-schz).  
 
Figure S3. Lysosome association with the parasitophorous vacuole (PVM). 
HepG2 cells were infected with Plasmodium berghei parasites and fixed at different 
developmental stages. The slides were stained with a combination of antisera 
specific for a PVM marker protein (sporozoite: UIS4; early and late schizont: Exp1) 
and the lysosome marker LAMP1. Staining of the DNA with DAPI was also 
performed. LAMP1 colocalizes with the PVM at the early stages of parasite 
development, which indicates the presence of lysosomes at the PVM at these stages. 
Scale bars: 10 µm. 
 
Figure S4. Accumulation of LC3 and degradation markers in early-stage 
parasites. GFP-LC3 transfected HepG2 cells were infected with wild type 
Plasmodium berghei sporozoites, labeled with different lysosomal markers, and 
analyzed by live microscopy. (A) LysoTracker was added to the medium of the 
infected wells 10 minutes before the analysis at different developmental stages. (B) 
Proteolytic activity was qualitatively indicated by staining with DQ-BSA red. The 
infected cells were monitored at different developmental stages of the parasite and 
representative images are presented. (C) HepG2 cells were double-transfected with 
the LC3 and Cathepsin D expression plasmids. Cathepsin D (red) and GFP-LC3 
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(green) expression is presented for different developmental stages of the parasite. In 
all experiments, DNA was stained with Hoechst 33342. Scale bars: 10 µm. 
 
 
Figure S5. Lysosome colocalization with LC3 at early developmental stages. 
GFP-LC3-expressing HepG2 cells were infected with Plasmodium berghei wild-type 
parasites and fixed at different developmental stages. The slides were stained with 
antibodies specific for the lysosome marker LAMP1 and with the DNA dye DAPI. 
LAMP1 colocalizes with the autophagy marker LC3 at the sporozoite stage and 
during early schizogony. Scale bars: 10 µm. 
 
Figure S6. Galectins are not involved in LC3 recruitment to the PVM. HepG2 
cells expressing the indicated YFP-tagged galectins were infected with mCherry 
Plasmodium berghei. Cells were fixed at different time points after infection: (A) 6 hpi; 
(B) 24 hpi; (C) 48 hpi, and galectins were stained with an antibody against GFP that 
also recognizes YFP. Cells were stained in addition with Dapi and this was included 
in the merged images.  
 
Figure S7. Generation and analysis of the P. berghei ANKA reporter line 
mCherryhsp70+Luceef1α, expressing mCherry under the control of hsp70 
promoter and luciferase under the control of the eef1α promoter. 
(A) Schematic representation showing the introduction of mCherry-reporter cassette 
(pL1720) into the GIMOANKA (line 1596cl1). Construct pL1720 contains the 5’hsp70 
(promoter)-mCherry-3’hsp70 (terminator) cassette and the 5’eef1α (promoter)-
luciferase-3’pbdhfr/ts cassette. The construct integrates into the modified P. berghei 
230p locus containing the hdhfr::yfcu selectable marker cassette by double cross-
over homologous recombination at the target regions (grey boxes). Negative 
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selection with 5-FC selects for the transgenic parasite line PbmCherryhsp70+Luceef1α 
(1868cl1) that have the mCherry/Luciferases cassettes introduced into the 230p 
locus and the hdhfr::yfcu marker removed. (B) Southern analysis of separated 
chromosomes  confirms the correct integration of construct pL1720 into the P. 
berghei genome thereby creating mCherryhsp70+Luceef1α. For Southern analysis, PFG-
separated chromosomes of the GIMO (ANKA) Motherline46 as well as clone 1 (cl1) 
and 2  (cl2) of  mCherryhsp70+Luceef1α were hybridized (left hand side) using a mixture 
of two probes: a control probe recognizing p25 on chromosome 5 (chr. 5) and an 
hdhfr probe recognizing hdhfr::yfcu. In addition (right hand side) a 3′UTR pbdhfr/ts 
probe that recognizes the hdhfr::yfcu selectable marker cassette in the GIMOANKA line 
in the 230p locus on chromosome 3 and the endogenous locus of dhfr/ts on 
chromosome 7 of both the GIMOANKA and mCherryhsp70+Luceef1α cloned lines. In 
addition, chromosomes are hybridized to a probe recognizing  hdhfr showing the 
removal of the hdhfr::yfcu SM cassette in mCherryhsp70+Luceef1α. (C) mCherry 
expression in various liver stages of mCherryhsp70+Luceef1α. HepG2 cells were 
infected with mCherryhsp70+Luceef1α sporozoites and were monitored 12, 48 and 56  
hours after infection. (D) Luciferase expression in livers of mice infected with 
mCherryhsp70+Luceef1α 12, 44, 140 hours after intravenous injection of 
mCherryhsp70+Luceef1α sporozoites. (E) mCherryhsp70+Luceef1α parasites have a blood 
stage asexual multiplication rate and gametocyte production  that is comparable to 
wild type P. berghei ANKA parasites. 
 
Figure S8. Fasting and rapamycin treatment induce canonical autophagy in 
hepatocytes in vivo. (A) Representative images obtained by intravital microscopy 
performed in 3 groups of naïve LC3-GFP transgenic mice, namely a) control mice 
untreated, fed ad libidum; b) mice fasting for 30h; and c) 24h post-treatment of mice 
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with Rapamycin. (B) LC3 punctae, representative of autophagy activation, were 
quantified for all conditions in vivo per hepatocyte.  
 
Figure S9. Assessment of the effect of autophagy induction and inhibition on 
parasite liver-stage development by in vivo bioluminescence (details of Fig 10B 
with individual significance assessments). Balb/c mice were infected by 
intravenous (i.v.) injection of 1x105 PbmCherryhsp70+Luceef1α sporozoites. Mice were 
divided into: a control group untreated; a control group injected with solution media 
only; a group treated with rapamycin 12 and 24hpi; a group pre-treated with 
rapamycin 12h prior to infection, and 12hpi; a group treated with chloroquine 12 and 
24hpi; a group pre-treated with chloroquine 12h prior to infection and 12hpi parasite 
development was assessed by whole body luminescence at (A) 12 hpi, (B) 24 hpi, 
(C) 36 hpi and (D) 44 hpi in mice. ROI measurements for the liver area of all mice 
(n=15) were recorded as photons per second per area (photons/s/cm2) for firefly 
luciferase. Experiments were repeated in triplicate (error bars show SD;  
* p=0.05; ** p=0.01; ***p<0.001  
 
Legends to Videos 
 
Video S1. Intravital observation of a dying late liver-stage parasite removed by 
autophagy. GFP-LC3-expressing mice were infected with mCherry-expressing 
Plasmodium berghei sporozoites. Intravital imaging of late liver-stage development 
from 40 hours post-infection until 44 hours post-infection was performed. 
 
Video S2. In vitro live imaging of a dying late liver-stage parasite removed by 
autophagy. GFP-LC3-expressing HepG2 cells were infected with mCherry 
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expressing Plasmodium berghei sporozoites and monitored by confocal live imaging 
at late schizogony. Images were acquired every 6.5 minutes. Scale bar: 10 µm. 
 
Video S3. LC3 accumulates around invading sporozoites. GFP-LC3-expressing 
HepG2 cells were infected with mCherry-expressing Plasmodium berghei sporozoites 
and then immediately monitored by confocal live imaging. Scale bar: 10 µm. Images 
were acquired every 2.06 minutes. 
 
Video S4. Normally developing parasites associate with the loss of LC3 from 
the PVM. GFP-LC3-transfected HepG2 cells were infected with mCherry-expressing 
Plasmodium berghei sporozoites and monitored by confocal live imaging from early 
schizogony to late schizogony, starting 24 hours post-infection and continuing until 44 
hours post-infection. Images were acquired every 7.7 minutes. Scale bar: 10 µm. 
 
Video S5. LC3 dynamics during schizogony. GFP-LC3-expressing HepG2 cells 
were infected with mCherry-expressing Plasmodium berghei sporozoites and 
monitored by confocal live imaging from early to late schizogony, starting 24 hours 
post-infection and continuing until 38.4 hours post-infection. Images were acquired 
every 7.9 minutes. Scale bar: 10 µm. 
 
Video S6. LC3 dynamics during the entire parasite development period. GFP-
LC3-transfected cells were infected with mCherry-expressing Plasmodium berghei 
and monitored from the sporozoite stage (6 hours post-infection) until the formation of 
merozoites (70 hours post-infection). Images were acquired every 1 hour. Scale bar: 
25 µm. 
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Video S7. Growth impairment and elimination of parasites that cannot remove 
LC3 from the PVM. GFP-LC3-expressing HepG2 cells were infected with mCherry-
expressing Plasmodium berghei sporozoites and monitored by confocal live imaging, 
starting at the schizont stage 30 hours post-infection and continuing until 42 hours 
post-infection. Images were acquired every 6.9 minutes. Scale bars 10 µm. 
 
Video S8. Lysosome fusion with the parasitophorous vacuole (PVM). LAMP1-
GFP transfected HepG2 cells infected with PbExp1-mCherry-expressing Plasmodium 
berghei sporozoites were monitored by confocal live imaging during early 
schizogony. Scale bars: 10 µm. 
 
Video S9. Association of ubiquitin and LC3 during sporozoite invasion. HepG2 
cells double-transfected with RFP-LC3 and GFP-ubiquitin were infected with wild 
type Plasmodium berghei sporozoites and monitored early after infection (1 hour 
post-infection). Yellow staining corresponds to colocalization of LC3 and ubiquitin. 
Images were acquired every 1.36 minutes. Scale bar: 10 µm. 
 
Video S10. Canonical autophagy during schizogony of the parasite. GFP-LC3-
expressing HepG2 cells were infected with mCherry-expressing Plasmodium berghei 
sporozoites and monitored by confocal live imaging, starting from late schizogony 
and continuing until merozoite formation. Monitoring began 55 hours post-infection 
and continued for 12 hours. Images were acquired every 12 minutes. Scale bar: 10 
µm. 
 
 
 











